MedTrace Logo

Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma

NCT01272102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2013-06-25

No results posted yet for this study

Summary

To determine the area under the Receiver Operator Characteristic Curve (AUC) for the Ganglion Cell Analysis (GCA) average thickness.

Conditions

Sponsors & Collaborators

  • DataMed Devices Inc.

    collaborator INDUSTRY

  • Carl Zeiss Meditec, Inc.

    lead INDUSTRY

Principal Investigators

  • Donald Budenz, MD · Bascom Palmer Eye Institute

  • Robert Chang, MD · Stanford Eye Institute

  • Arvind Neelakantan, MD · Glaucoma Associates of Texas

  • Alan Crandall, MD · Utah Eye Institute

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01272102 on ClinicalTrials.gov